Autolus Therapeutics plc American Depositary Share

AUTLNASDAQ • USD
1.40 USD
↗ 0.03 (1.80%)🟢PRE MARKET (AS OF 06:10 AM EDT)
🟢Market: OPEN
Open?$1.40
High?$1.42
Low?$1.40
Prev. Close?$1.39
Volume?2.5K
Avg. Volume?N/A
VWAP?$1.42
Bid / Ask
Bid?$1.17 × 100
Ask?$1.59 × 100
Spread?$0.42
Midpoint?$1.38
Valuation & Ratios
Market Cap?369.9M
Shares Out?266.1M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Employees
752
Market Cap
369.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.autolus.com
Listed
2018-06-22
Address
THE MEDIAWORKS
LONDON, X0 W12 7FP
Phone: 44 20 3829 6230
MarketsMoversWatchlist